Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BPLPHARMA.BOthis companyBharat Parenterals Limited	₹1,813.35	-22.72×	0.58×	0.54×	12.63×	-722.6%	15.2%	-5.3%	-2.4%	-2.5%	-3.8%	-5.6%	0.45×	5.29×	-1.47×	1.97×	0.4%	3	3.1	2	C
ALPA.NSAlpa Laboratories Limited	₹56.58	6.52×	0.52×	0.92×	5.12×	43.1%	12.9%	1.1%	14.2%	8.1%	0.6%	8.7%	0.01×	-0.02×	4.64×	4.01×	0.0%	5	—	2	B-
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BDH.BOBDH Industries Limited	₹414.55	18.78×	2.64×	2.12×	10.9×	99.9%	18.4%	13.6%	11.3%	14.0%	11.4%	-0.1%	0.03×	-1.7×	213.65×	4×	1.3%	4	—	2	B-
BIBCL.BOBharat Immunologicals & Biologicals Corporation Limited	₹8.75	-5.76×	1.09×	2.15×	-10.33×	-386.4%	-32.9%	-21.7%	-37.3%	-18.9%	-4.4%	11.4%	0.8×	-4.32×	-1.38×	0.38×	0.0%	1	-0.46	—	—
KPL.BOKwality Pharmaceuticals Limited	₹3,856.75	20.13×	4.09×	2.69×	12.56×	-80.9%	33.9%	19.6%	13.4%	20.3%	15.8%	-2.9%	0.39×	1.1×	8.97×	1.8×	0.0%	4	—	2	C
Peer median	—	18.78×	2.64×	2.12×	10.9×	-80.9%	13.4%	6.6%	11.3%	11.5%	7.2%	-0.1%	0.39×	-0.02×	4.64×	1.8×	0.0%	4	-0.46	2	—